Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia. - Suppr | 超能文献

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.

作者信息

Alphs Larry, Olson William H, Turkoz Ibrahim, Fastenau John, Hulihan Joseph

出版信息

J Clin Psychiatry. 2012 Oct;73(10):1358; author reply 1358-9. doi: 10.4088/JCP.12lr07934.

DOI:10.4088/JCP.12lr07934

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.

J Clin Psychiatry. 2012 Oct;73(10):1358; author reply 1358-9. doi: 10.4088/JCP.12lr07934.

2

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.

J Clin Psychiatry. 2012 May;73(5):696-702. doi: 10.4088/JCP.11m07070.

3

Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.

Appl Health Econ Health Policy. 2008;6(1):41-53. doi: 10.2165/00148365-200806010-00004.

4

Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial.

Value Health. 2006 Mar-Apr;9(2):77-89. doi: 10.1111/j.1524-4733.2006.00083.x.

5

Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.

J Clin Psychiatry. 2003 May;64(5):589-97.

6

Comments to the editor on "Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model".

Value Health. 2005 Mar-Apr;8(2):175-6. doi: 10.1111/j.1524-4733.2005.08204.x.

7

Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: an approach using generalised estimating equations.

Psychiatry Res. 2013 Dec 30;210(3):745-50. doi: 10.1016/j.psychres.2013.07.012. Epub 2013 Sep 3.

8

Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.

Psychiatry Clin Neurosci. 2005 Aug;59(4):385-94. doi: 10.1111/j.1440-1819.2005.01390.x.

9

Impact of splitting risperidone tablets on medication adherence and on clinical outcomes for patients with schizophrenia.

Psychiatr Serv. 2007 Feb;58(2):201-6. doi: 10.1176/ps.2007.58.2.201.

10

Pharmacoeconomics of antipsychotic drug therapy.

J Clin Psychiatry. 1996;57 Suppl 9:66-76.